💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for BioMarin Pharmaceutical Inc. (BMRN)
« Back to company indexBMRN Chatter Timeline
Stock Ticker for BMRN
Most Active Tweeters for BMRN
| User | Tweets |
|---|---|
| @TradingSin21 | 7 |
| @Tickeron | 7 |
| @MarcJacksonLA | 5 |
| @BiotechAnalysst | 5 |
| @Varro_Analytics | 5 |
Recent Tweets for BMRN
 |
@George1_4 RT @Tickeron: $BMRN's 10-day Moving Average moved below its 50-day Moving Average on September 14, 2022. View odds for this and other indic… September 25th 2022, 10:09am |
 |
@Tickeron $BMRN's 10-day Moving Average moved below its 50-day Moving Average on September 14, 2022. View odds for this and o… https://t.co/iZOWD0BlD0 September 25th 2022, 10:09am |
 |
@TradingSin21 $BMRN Trading Ideas | Awaiting Buy signal. 64.29% Profitability based on 16 trades. Profit factor is 2.48. Learn mo… https://t.co/s4SLugMTRc September 25th 2022, 7:09am |
 |
@Varro_Analytics A $BMRN $SYBX deal might not quite trigger FTC scrutiny because 75% of the market isn’t treated (BH4-agnostic popul… https://t.co/Cu6G76r4mB September 25th 2022, 4:09am |
|
@Varro_Analytics Could $BMRN acquire $SYBX or would that trigger FTC scrutiny because Palynziq is the standard of care for #PKU? (Ge… https://t.co/v81J8ew5Cf September 24th 2022, 11:09pm |
|
@Varro_Analytics Here are the two #PKU competitor drugs from $BMRN, Palyziq / pegvaliase (? FDA approved in 2018) and Kuvan / saprop… https://t.co/Q4NvpaKyEh September 24th 2022, 11:09pm |
|
@Varro_Analytics Does anyone know any metabolic disease specialists on Twitter? Wondering if $BMRN ‘s Palynziq’s REMS and injectab… https://t.co/lNO91bV4HS September 24th 2022, 9:09pm |
|
@Varro_Analytics How good will Ph2 $SYBX #PKU primary endpt data have to be to impress? And unseat $BMRN injectable protein drug,… https://t.co/kQv4oTUFC8 September 24th 2022, 7:09pm |
|
@Tickeron $BMRN enters a Downtrend because Momentum Indicator dropped below the 0 level on September 9, 2022. View odds for t… https://t.co/JjhB6Pd21P September 24th 2022, 5:09am |
 |
@TradeWithAlerts Nice print for $BMRN Size: 110977 Price: 84.84 Amount: $9,415,288.68 Time: 1600 See more: https://t.co/gVRBskXrV9 J… https://t.co/la8NWgfo2j September 23rd 2022, 8:09pm |
 |
@LeviTrade2 $BMRN Bullish technical pattern based on 11 trades. Start Free Trial at https://t.co/z546jb65wN .#BMRN… https://t.co/xpaRFlu3yL September 23rd 2022, 4:09pm |
 |
@Richard00617124 $BMRN Don't miss the next move in a few hours. https://t.co/JgYIsnGmRh September 23rd 2022, 2:09pm |
|
@LeviTrade2 $BMRN Waiting for Buy signal based on 11 trades. Learn more at https://t.co/d0Hu3BtrQ8 https://t.co/IkbN6tUdEs September 22nd 2022, 11:09pm |
|
@TradeWithAlerts Nice print for $BMRN Size: 113130 Price: 84.92 Amount: $9,606,999.60 Time: 1600 See more: https://t.co/gVRBskXrV9 J… https://t.co/Sc2aUbTrHD September 22nd 2022, 8:09pm |
|
@TradingSin21 $BMRN Trading Ideas | Awaiting Buy signal. 83.33% Profitability based on 7 trades. Profit factor is 4.66. Learn mor… https://t.co/wkpduN7hsy September 22nd 2022, 12:09pm |
|
@Tickeron $BMRN's price moved below its 50-day Moving Average on September 13, 2022. View odds for this and other indicators:… https://t.co/PTgqstVLJr September 22nd 2022, 5:09am |
 |
@direports Update: BioMarin Pharmaceutical Inc. $BMRN 08-Jul-2022, FOIA Response - No recent SEC investigative activity fou… https://t.co/TfKs06g0D1 September 20th 2022, 2:09pm |
|
@Tickeron $BMRN's 10-day Moving Average moved below its 50-day Moving Average on September 14, 2022. View odds for this and o… https://t.co/ujVYx0l5sp September 20th 2022, 2:09pm |
|
@TradingSin21 $BMRN Trading Ideas | Awaiting Buy signal. 100% Profitability based on 8 trades. Profit factor is 100. Learn more a… https://t.co/Ht7iuaI4Yg September 20th 2022, 12:09pm |
|
@TradingSin21 $BMRN Trading Ideas | Awaiting Buy signal. 100% Profitability based on 7 trades. Profit factor is 100. Learn more a… https://t.co/tOGd9MoMuc September 18th 2022, 8:09pm |
|
@Tickeron $BMRN's 10-day Moving Average broke below its 50-day Moving Average on September 14, 2022. View odds for this and o… https://t.co/EbrCwFrxcJ September 18th 2022, 1:09pm |
 |
@FZucch1 RT @FZucchi: Good data bits on $BMRN here https://t.co/j24h5Y0F4e September 17th 2022, 5:09pm |
|
@FZucch1 RT @FZucchi: New 2yr closing high. Dare I dream? $BMRN https://t.co/z8KnFmFqmI September 17th 2022, 5:09pm |
|
@FZucch1 RT @FZucchi: Not sure if this is how @hmeisler would draw the lines on $BMRN but they have worked so far. Still think this one does not exi… September 17th 2022, 5:09pm |
|
@TradingSin21 $BMRN Trading Ideas | Awaiting Buy signal. 100% Profitability based on 7 trades. Profit factor is 100. Learn more a… https://t.co/yeMkJIRLIc September 17th 2022, 2:09pm |
|
@TradingSin21 $BMRN Trading Ideas | Awaiting Short signal. 100% Profitability based on 7 trades. Profit factor is 100. Learn more… https://t.co/GovoF74yNf September 16th 2022, 7:09pm |
|
@Tickeron $BMRN's 10-day Moving Average broke below its 50-day Moving Average on September 14, 2022. View odds for this and o… https://t.co/sbOp5rTWHU September 16th 2022, 1:09pm |
 |
@42Stocks 2022-09-15 4:00 PM $BMRN BioMarin Pharmaceutical up 1.42% = $228.77 million gain. https://t.co/4w3h4Zeo8X (Sep 13)… https://t.co/LRFf9oZT18 September 15th 2022, 11:09pm |
 |
@mediasentiment $BMRN new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 647 September 15th 2022, 5:09pm |
|
@mediasentiment $BMRN new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 646 September 15th 2022, 5:09pm |
 |
@Xarahenergy RT @MarketCurrents: $BMRN $RHHBY - BioMarin touts report on cost effectiveness of gene therapy Roctavian for hemophilia A https://t.co/FzVe… September 15th 2022, 4:09pm |
 |
@Briefingcom $BMRN: BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN (valoctocogene roxaparvovec), Assesse… https://t.co/aJ6fOfob6b September 15th 2022, 2:09pm |
 |
@MarcJacksonLA $BMRN $RHHBY BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN™ (valoctocogene roxaparvovec),… https://t.co/KiIK5n8NI5 September 15th 2022, 2:09pm |
 |
@MarketCurrents $BMRN $RHHBY - BioMarin touts report on cost effectiveness of gene therapy Roctavian for hemophilia A https://t.co/FzVeie5c2N September 15th 2022, 1:09pm |
 |
@ohadhammer RT @adar170: $BMRN ICER likes Valarox https://t.co/WiTrNmNexP September 15th 2022, 1:09pm |
 |
@adar170 $BMRN ICER likes Valarox https://t.co/WiTrNmNexP September 15th 2022, 1:09pm |
|
@Tickeron $BMRN's 10-day Moving Average crossed below its 50-day Moving Average on September 14, 2022. View odds for this and… https://t.co/4y889xu0UV September 15th 2022, 1:09pm |
 |
@BloombergFeed $BMRN BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN™ (valoctocogene roxaparvovec), Assesse… https://t.co/WFy0aLXFIh September 15th 2022, 12:09pm |
 |
@James__BondOO7 RT @stock_titan: $BMRN BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN™ (valoctocogene roxaparvovec), Assessed to Pr… September 15th 2022, 12:09pm |
 |
@StockNewsBot2 $BMRN BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN™ (valoctocogene roxaparvovec), Assesse… https://t.co/IVVq7DaqSB September 15th 2022, 12:09pm |
 |
@stonkmooncom $BMRN 2022-09-15 08:31 ET BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN™ (valoctocogene… https://t.co/vnP2om1Gnc September 15th 2022, 12:09pm |
 |
@FastestAlert $BMRN BioMarin's Gene Therapy For Adults With Severe Hemophilia A, ROCTAVIAN™ (valoctocogene Roxaparvovec), Assesse… https://t.co/Vgd97x72Lb September 15th 2022, 12:09pm |
 |
@stock_titan $BMRN BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN™ (valoctocogene roxaparvovec), Assesse… https://t.co/P2DFxngFzM September 15th 2022, 12:09pm |
 |
@UsMarketNews $BMRN news BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN (valoctocogene roxaparvovec), Ass… https://t.co/3vnsmQ7AKT September 15th 2022, 12:09pm |
 |
@WebChronicleTo1 $BMRN BioMarin's Gene Therapy for Adults with Severe Hemophilia A, ROCTAVIAN™ (valoctocogene roxaparvovec), Assesse… https://t.co/9Jk5NYOUDv September 15th 2022, 12:09pm |
 |
@Scarlet71737977 $bmrn Top analyst price target for next week:~ https://t.co/XeMxWDSJfO September 15th 2022, 4:09am |
 |
@DanielI84125352 $bmrn This week's top analyst price target.. https://t.co/mvYiezXJiY September 14th 2022, 11:09am |
 |
@BiotechAnalysst RT @OxAnalyst: $BMRN Valrox case of B-ALL https://t.co/tZQVEmcaMc September 14th 2022, 10:09am |
|
@BiotechAnalysst RT @BentheFidler: BioMarin reports cancer case in #hemophilia gene therapy trial https://t.co/ddlB5siW8K @ByJonGardner $BMRN September 14th 2022, 10:09am |
|
@BiotechAnalysst RT @BiotechAnalysst: $BMRN BioMarin finds the #cancer is unrelated to #ROCTAVIAN as preliminary results indicate 85% of leukemic cells carr… September 14th 2022, 10:09am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.